SCHEMBL29946509

SCHEMBL29946509

O=C(O)c1ccccc1NC(=O)c1c(O)ccc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.56
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
RAB9A P51151 1/20 0.53
LMNA P02545 1/20 0.52
PTGER4 P35408 1/20 0.52
CDC25B P30305 3/20 0.51
EGFR P00533 1/20 0.50
SRC P12931 1/20 0.50
PKM P14618 1/20 0.50
ALOX15 P16050 1/20 0.50
SOS1 Q07889 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568133 0.86 KDM4E (0.50) GFERALDH1A1KDM4EMEN1KMT2A
SCHEMBL22750628 0.85 KDM4E (0.57) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL22758443 0.82 ALDH1A1 (0.51) GFERALDH1A1KDM4EMEN1KMT2A
SCHEMBL11777297 0.81 MEN1 (0.55) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL9281809 0.80 GFER (0.76) GFERALDH1A1KDM4EMEN1KMT2A
SCHEMBL4971446 0.80 ALOX15 (0.67) KDM4EMEN1KMT2AHPGDSMN1; SMN2
SCHEMBL24953153 0.77 ALOX15 (0.56) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL29625679 0.77 ALOX15 (0.56) ALDH1A1KDM4EMEN1KMT2AHPGD
Salicylic Acid SCHEMBL17712461 0.77 ALDH1A1 (0.60) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4593816 0.77 CDC25B (0.61) GFERKDM4EMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220304958-A1 SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220304958-A1 SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX SERBP1, PPHLN1, VCAM1 GFER 4298/4885ALDH1A1 4523/4885KDM4E 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.